enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Monoclonal antibody therapy - Wikipedia

    en.wikipedia.org/wiki/Monoclonal_antibody_therapy

    The first FDA-approved therapeutic monoclonal antibody was a murine IgG2a CD3 specific transplant rejection drug, OKT3 (also called muromonab), in 1986. This drug found use in solid organ transplant recipients who became steroid resistant. [39] Hundreds of therapies are undergoing clinical trials. Most are concerned with immunological and ...

  3. Muromonab-CD3 - Wikipedia

    en.wikipedia.org/wiki/Muromonab-CD3

    Muromonab-CD3 was approved by the U.S. Food and Drug Administration (FDA) in 1986, [5] making it the first monoclonal antibody to be approved anywhere as a drug for humans. In the European Communities , it is the first drug to be approved under the directive 87/22/EWG, a precursor of the European Medicines Agency (EMA) centralised approval ...

  4. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page. This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources .

  5. Monoclonal antibody - Wikipedia

    en.wikipedia.org/wiki/Monoclonal_antibody

    A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a unique parent cell.

  6. Belantamab mafodotin - Wikipedia

    en.wikipedia.org/wiki/Belantamab_mafodotin

    Belantamab mafodotin was approved for medical use in the United States and in the European Union in August 2020. [5] [6] [3] The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. [7] [8]

  7. Eculizumab - Wikipedia

    en.wikipedia.org/wiki/Eculizumab

    The FDA approval in 2011 was based on two small prospective trials of 17 people and 20 people. [ 15 ] [ 8 ] [ 23 ] The European Medicines Agency approved it for the treatment of paroxysmal nocturnal hemoglobinuria in June 2007, [ 7 ] and in November 2011, for the treatment of atypical hemolytic uremic syndrome. [ 24 ]

  8. Stock up on KN95s after the updated CDC guidelines: These FDA ...

    www.aol.com/lifestyle/stock-kn95s-updated-cdc...

    Stock up on KN95s after the updated CDC guidelines: These FDA-approved masks are on sale for $1 a pop at Amazon Devon Kelley,Izabella Zaydenberg July 30, 2021 at 3:23 PM

  9. Nomenclature of monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/Nomenclature_of_monoclonal...

    The nomenclature of monoclonal antibodies is a naming scheme for assigning generic, or nonproprietary, names to monoclonal antibodies.An antibody is a protein that is produced in B cells and used by the immune system of humans and other vertebrate animals to identify a specific foreign object like a bacterium or a virus.